By: Barsha Nandy  Oct. 13, 2020

Dexur analyzed Medicare Claims data and replicated CMS algorithms to calculate Medicare Spending per Beneficiary (MSPB) cost per episode of New Hanover Regional Medical Center and found that the cost per episode was $74,289 for Cervical Spinal Fusion from Jan-Dec 2019. The cost increased by 36.41% in 2019 to reach $74,289 compared to $54,460 in 2018. MSPB is the only measure under the Efficiency and Cost Reduction domain under the Value-Based Purchasing (VBP) Program and accounts for 25% of VBP adjustments.

By: Barsha Nandy  Oct. 12, 2020

Dexur provides critical volume and quality outcomes data to Orthopedic Network News, a leading Orthopedic research publication, that is read by orthopedic surgeons and hospitals. The data has been used to publish statistics on quality outcomes, shifts in care from inpatient to outpatient and other emerging trends.

By: Parvathy Rajagopal  Oct. 09, 2020

Dexur analyzed the Medicare Claims data to evaluate Value-Based Purchasing(VBP) payment adjustment and found that Renown Regional Medical Center in Reno, Nevada, had a projected negative financial impact of $178,000 in 2020. During FY 2020, the VBP adjustment factor was 0.99 which reflected a VBP payment adjustment percentage of -0.16.

By: Barsha Nandy  Oct. 06, 2020

Dexur analyzed Medicare Claims data to evaluate Value-Based Purchasing (VBP) payment adjustment and found that Ocala Regional Medical Center had the highest projected negative financial impact of $1.2m. For FY 2020, their VBP adjustment factor was 0.986, which translated into a payment adjustment percentage of -1.4. The adjustment amount has gradually increased, almost by 30%, since an adjustment of $830,288 was made in 2018 against Ocala’s favor.

Heron Therapeutics, Inc., a commercial-stage biotechnology company utilizes Dexur’s App suite to increase velocity in commercial operations.

“Dexur’s App Suite and implementation services is a key strategic partner to help scale ClearFlow. The breadth and depth of Dexur’s offering across data, sales analytics, and marketing automation has made Dexur a critical element in articulating ClearFlow’s value to healthcare providers” said Paul Molloy, CEO of ClearFlow.

By: Barsha Nandy  Oct. 01, 2020

Dexur analyzed Medicare Claims data to evaluate Bundled Payments for Care Improvement Advanced (BPCI-A) episode costs for Inpatient Hip and Knee Replacement Surgery in Texas and found that Baylor Hospitals in Frisco, Sherman, Fort Worth & Trophy Club performed the best and reduced total costs by 10-20%. The biggest cause of these changes was a reduction in post anchor stay costs of Rehospitalizations, Skilled Nursing Homes & Home Health. Providence (Waco), Medical City (Plano, Arlington), Texoma (Denniston) Hospital saw little change or increased costs under the same program.

AltaThera Pharmaceuticals, a hospital specialty pharmaceutical company focused on commercializing innovative drugs aimed at improving outcomes and reducing hospital costs, chose Dexur’s App Suite to help scale the operations of the company. AltaThera recently received approval from the FDA for new indications of Sotalol IV, to help hospitals manage patients with Afib.

By: Parvathy Rajagopal  Sep. 23, 2020

Dexur’s analysis of Medicare claims of hospitals within a 10-mile radius of Slidell, LA, showed that Ochsner Medical Center - NorthShore and Slidell Memorial Hospital had the best value outcomes over a 90-day episode for Sepsis. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days, including the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. The total cost of care data helps patients make appropriate choices and helps local ACOs make appropriate referrals choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 871: Septicemia or Severe Sepsis without MV >96 Hours with Major Complication or Comorbidity, to adjust for complications and comorbidities.